Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Visningar
• 07/04/23
0
0
Bädda in
administrator
Prenumeranter
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna